Bank Of America Corp Amylyx Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 2,426,263 shares of AMLX stock, worth $8.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,426,263
Previous 912,515
165.89%
Holding current value
$8.64 Million
Previous $2.96 Million
209.44%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMLX
# of Institutions
141Shares Held
49.1MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$24.1 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$16.5 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$9.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$9.5 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA2.03MShares$7.24 Million3.73% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $208M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...